Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

Lars Sävendahl; Effie Pournara; Bente Klarlund Pedersen; Oliver Blankenstein

doi:10.1530/eje-15-1017

February 23, 2016European Journal of Endocrinology

Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

We conclude that safety data from NordiNet(®) IOS do not reveal any new safety signals and confirm a favorable overall safety profile in accordance with other pediatric observational studies. No association between growth hormone dose and the incidence of AEs during growth hormone treatment in childhood was found.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sävendahl et al. (2016) studied this question.

synapsesocial.com/papers/69dd37e399c691022d99b63d https://doi.org/10.1530/eje-15-1017

View at Publisher

Ask AI

Bookmark

Share

Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

Ask about this paper

Abstract

Discussion

Cite This Study

Is safety of childhood growth hormone therapy related to dose? Data from a large observational study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading